Physician profile
Beman Khulpateea
NPI 1558597757
$2,031.94
in general payments reported to CMS, 2019-2025
20 companies · $60.09 in 2025
The $60.09 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,228 · 2021: $148 · 2022: $170 · 2023: $192 · 2024: $234 · 2025: $60.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $487.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $507.96 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $381.15 | 2019-2022 | |
| Baxter Healthcare | $377.00 | 2021-2024 | Tisseel |
| Genentech USA, INC. | $126.98 | 2019 | |
| Tesaro, INC. | $110.11 | 2019 | |
| Clovis Oncology, INC. | $99.00 | 2019 | |
| Merck Sharp & Dohme LLC | $81.79 | 2019-2023 | Keytruda, Lenvima |
| Seagen INC. | $69.41 | 2022-2023 | Tivdak |
| Ethicon US, LLC | $42.00 | 2024 | Enseal |
| Convatec INC. | $25.90 | 2021 | |
| Myovant Sciences INC. | $23.44 | 2022 | |
| Medtronic, INC. | $23.19 | 2022 | |
| Conmed Corporation | $22.80 | 2025 | Airseal |
| Mayne Pharma Commercial LLC | $22.22 | 2022 | |
| Tempus Ai, INC | $22.00 | 2024 | Xt Cdx |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $21.72 | 2024 | |
| Therapeuticsmd, INC. | $19.96 | 2021 | |
| Astellas Pharma US INC | $19.09 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $18.20 | 2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Acessa Provu System |
| Myriad Genetic Laboratories, INC. | $18.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beman Khulpateea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.